| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 142.44B | 155.64B | 142.99B | 120.44B | 113.52B | 93.75B |
| Gross Profit | 118.72B | 128.79B | 115.24B | 98.44B | 103.25B | 89.19B |
| EBITDA | 26.85B | 31.63B | 27.75B | 26.14B | 22.01B | 25.66B |
| Net Income | 19.75B | 21.29B | 18.72B | 15.94B | 14.86B | 17.71B |
Balance Sheet | ||||||
| Total Assets | 7.64T | 7.67T | 7.53T | 7.97T | 7.31T | 7.54T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.04T | 898.94B | 1.36T | 1.20T | 1.75T |
| Total Debt | 1.27T | 1.01T | 1.21T | 1.47T | 776.55B | 1.27T |
| Total Liabilities | 7.18T | 7.16T | 7.08T | 7.48T | 6.86T | 7.07T |
| Stockholders Equity | 456.91B | 509.02B | 444.81B | 490.89B | 441.22B | 464.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.37B | 0.00 | 368.47B | -488.52B | 0.00 |
| Operating Cash Flow | 0.00 | 19.09B | 0.00 | 369.60B | -483.43B | 0.00 |
| Investing Cash Flow | 0.00 | 51.47B | -47.63B | -288.59B | -57.99B | 21.82B |
| Financing Cash Flow | 0.00 | 42.67B | -381.21B | 565.53B | -7.95B | 200.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥491.95B | 13.64 | 3.95% | 2.19% | 16.41% | 51.17% | |
72 Outperform | ¥392.58B | 10.03 | 8.52% | 2.12% | 11.88% | 85.95% | |
71 Outperform | ¥363.25B | 11.59 | ― | 2.94% | 14.34% | 213.31% | |
70 Outperform | ¥312.18B | 13.05 | ― | 2.27% | 26.67% | 31.83% | |
69 Neutral | ¥267.90B | 12.97 | ― | 3.46% | 11.64% | 26.63% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥475.20B | 20.19 | ― | 1.50% | 18.76% | 15.43% |